An Open-label, Multicenter Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Effects of THB001 in Adult Patients With Chronic Cold Urticaria

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 12 Oct 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

25 Jul 2023 According to a Third Harmonic Bio. media release, the company plans to present the full results of the study at a scientific conference later this year.
29 Mar 2023 According to a Third Harmonic Bio. media release, the company plans to present the full data set from the five enrolled subjects at an upcoming scientific conference.
19 Dec 2022 Planned primary completion date changed from 1 Jun 2023 to 1 Mar 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com